Cygnokem Pharmaceuticals Private Limited, a active private limited company, was established on 02 March 2022 in Aurangabad, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MH2022PTC377820. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Vikas Mahadev Gadekar (Director), Kundan Shankarrao Pandharikar (Director), Dadasaheb Banshi Landge (Director). Past directors included Vasant Bhagavat Mahajan. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. B-202, Chandramouli Pinnacle Plot No 55/57, Satara Parisar, Aurangabad, Maharashtra, 431002.
U24230MH2022PTC377820
377820
02 March 2022
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cygnokem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Mahadev Gadekar | Director | 15 Mar 2022 | Current |
| Kundan Shankarrao Pandharikar | Director | 02 Mar 2022 | Current |
| Dadasaheb Banshi Landge | Director | 02 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Cygnokem Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Cygnokem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2023 | Others | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Cygnokem Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cygnokem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cygnokem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cygnokem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Cygnokem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.50 M with Charge ID 100811274 was registered on 25 Sep 2023. was completed.
Vikas Mahadev Gadekar was appointed as a Director was appointed as a Director on 15 Mar 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.
Progress on Kundan Shankarrao Pandharikar was appointed as a Director was appointed as a Director on 02 Mar 2022 & has been associated with this company since 3 years 9 months . was documented.
Progress on Dadasaheb Banshi Landge was appointed as a Director was appointed as a Director on 02 Mar 2022 & has been associated with this company since 3 years 9 months . was documented.
The CIN of Cygnokem Pharmaceuticals Private Limited is U24230MH2022PTC377820.
Cygnokem Pharmaceuticals Private Limited is headquartered at Flat No. B-202, Chandramouli Pinnacle Plot No 55/57, Satara Parisar, Aurangabad, Maharashtra, 431002.
Cygnokem Pharmaceuticals Private Limited was incorporated on 02 March 2022.
The current directors of Cygnokem Pharmaceuticals Private Limited are
The primary industry of Cygnokem Pharmaceuticals Private Limited is Chemicals.
Cygnokem Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cygnokem Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX